HISTOGENICS CORP Uncategorized Contracts & Agreements

Form of Non (Filed With SEC on February 28, 2023)

Second Amendment to the Co-Development and Commercialization Agreement, dated November 21, 2022, by and between the Registrant and CanSino Biologics, Inc (Filed With SEC on February 28, 2023)

First Amendment to the (Filed With SEC on February 28, 2023)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)

First Amendment to (Filed With SEC on November 9, 2021)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2021)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 27, 2020)

Form of In (Filed With SEC on March 27, 2020)

Co-Development and Commercialization Agreement, dated as of September 27, 2019, by and among the Registrant and CanSino Biologics Inc (Filed With SEC on November 12, 2019)

Form of Series A/B Warrants (Filed With SEC on June 14, 2019)

Form of Lock-Up Agreement (Filed With SEC on June 14, 2019)

Form of Lock-Up Agreement, dated April 5, 2019, by each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)

FIRST AMENDMENT TO AGREEMENT (Filed With SEC on August 11, 2016)

HISTOGENICS CORPORATION 830 Winter Street Waltham, MA 02451 January 30, 2015 (Filed With SEC on February 27, 2015)

Additional abbreviationsmay also be used though not in the above list. For Value Received, hereby sell, assign and transfer unto (Filed With SEC on November 7, 2014)

AMENDED AND RESTATED ROYALTY AGREEMENT (Filed With SEC on November 7, 2014)

HISTOGENICS CORPORATION SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT TABLE OF CONTENTS (Filed With SEC on October 7, 2014)

ROYALTY AGREEMENT (Filed With SEC on October 7, 2014)

INDEMNITY AGREEMENT (Filed With SEC on October 7, 2014)

Very truly yours, (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT TO LICENSEAGREEMENT (1st Amendment) (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on October 7, 2014)

FIRST AMENDMENT TO EXCLUSIVE AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED SECOND AMENDMENT TO EXCLUSIVE AGREEMENT (Filed With SEC on October 7, 2014)

AMENDMENT NO. 4 TO THELICENSE AGREEMENT EFFECTIVE 04/15/2001 BETWEEN STANFORD UNIVERSITY AND HISTOGENICS CORPORATION (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED LICENCE AGREEMENT Between YEDA RESEARCH ANDDEVELOPMENT COMPANY LIMITED (Filed With SEC on October 7, 2014)

HISTOGENICS CORPORATION 830 Winter Street Waltham, MA 02451 February 28, 2014 (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED COLLAGEN TECHNOLOGY TRANSFER AGREEMENT (Filed With SEC on October 7, 2014)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on October 7, 2014)